# Incretin-based Therapy in Early Diagnosed Type 1 Diabetes

> **NCT02908087** · PHASE2 · COMPLETED · sponsor: **University of Oulu** · enrollment: 13 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Victoza® (liraglutide)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02908087
- **Lead sponsor:** University of Oulu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02908087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02908087, "Incretin-based Therapy in Early Diagnosed Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02908087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*